Speaker

Speaker

Hok Bing Thio, MD, PhD, born 2 April 1960 in Surabaya (Indonesia), is a full-time dermatologist consultant and vice-chair at the department of dermatology, Erasmus Medical Centre, Rotterdam, The Netherlands. He is also chair of the dermatology residency program. His PhD thesis (1999) was entitled "Clinical and basic aspects of fumarates in psoriasis", and his main research interests are basic and clinical immunology, particularly the 2 main chronic immune-mediated inflammatory diseases (IMIDs) of the skin, psoriasis and atopic dermatitis (AD). Dr Thio has been the principal supervisor/investigator of clinical studies and translational research on psoriasis and AD.
Dr Thio has authored and co-authored several papers in peer-reviewed journals. More recently his field of interest has been focused on the interaction of the immune system and the gut- and skin microbiota. His clinical and scientific expertise with dimethylfumarate as immunomodulatory agent brings him into the field of various non-cutaneous IMIDs such as sarcoidosis, vasculitis, multiple sclerosis and lupus erythematosus. His other preferred topics of research include gut and skin microbiota, pruritus and the cutaneous impact of immunosenescence in ageing.